Study unveils mechanisms driving pain in myotonic disorders
Preclinical results point to the potential of targeted treatment for pain associated with this broad group of rare, inherited neuromuscular conditions.
Preclinical results point to the potential of targeted treatment for pain associated with this broad group of rare, inherited neuromuscular conditions.
New UF President Dr. Stuart Bell's tour of College of Medicine research kicked off at the MBI.
Our e-newsletter highlights some of the latest neuroscience and neuromedicine research and news across campus.
New project will identify mechanisms that support deception detection in older adults, including those with Alzheimer’s and related dementias.
At a key moment in dementia research, the UF-led 1Florida Alzheimer’s Disease Research Center has received a $22.3 million grant from the NIA to accelerate discoveries.
In Ethos, Dr. Tracy Centanni Rosen discussed the potential of vagus nerve stimulation to treat different conditions.
In The Washington Post, Dr. Ramon Sun discusses his study into glucosamine's effect on dementia.
The MBI’s Accelerator Program is an annual seed-funding initiative that supports novel, high-impact neuroscience and neuromedicine research.
UF is leading a team developing a battery‑free, needle‑injectable neural stimulator that shows promise in rodent models.
MBI researcher is a leader in immunotherapy approaches that harness the body’s immune system to combat cancer, particularly malignant brain tumors.